State medical cannabis programs developed product testing, labeling, licensing, inspection, and recall requirements without a coordinated federal framework. These systems provide important safeguards, but regulations alone do not guarantee that every product meets established standards or that problems will be identified promptly. Rules and enforcement for hemp-derived cannabinoid products also vary across jurisdictions, creating additional consumer-protection challenges. Patients and consumers need trustworthy laboratory results, accurate labels, and effective responses when unsafe products reach the market.

The Market Watch Award recognizes independent marketplace surveillance, consumer protection investigations, product testing, data analysis, labeling reviews, and public accountability initiatives that examine how cannabis safety systems perform in practice. By investigating products available to patients and consumers, this work can reveal discrepancies between regulatory requirements and marketplace conditions. Independent scrutiny helps identify weaknesses, verify product claims, uncover testing concerns, and provide regulators, businesses, and the public with evidence needed to strengthen protections.

The 2026 nominees, Patients for Safe Access of Oklahoma and the Institute of Cannabis Science, demonstrate complementary approaches to marketplace accountability. Patients for Safe Access of Oklahoma investigates concerns arising directly from patient experiences, while the Institute of Cannabis Science examines products, laboratory practices, regulatory information, and marketplace claims through independent scientific analysis. Their work reinforces the importance of verification and accountability as constructive parts of regulated cannabis markets, helping ensure that public confidence is earned through reliable protections.

Learn more about the Market Watch Award and the nominees' role in Cannabis Safety.